🇺🇸 FDA
Patent

US 12383538

Use of mTOR inhibitors for prevention of intestinal polyp growth and cancer

granted A61KA61K31/192A61K31/415

Quick answer

US patent 12383538 (Use of mTOR inhibitors for prevention of intestinal polyp growth and cancer) held by The Board of Regents of the University of Texas System expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/192, A61K31/415, A61K31/436, A61K45/06